BIOMAT Database Logo BIOMAT Database Logo

[The lymphokine-mediated activation of effector cells in the natural resistance system induced by gamma-interferon]. 1995

F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko

Some mechanisms of biologic action of gamma-interferon (INF) agents have been studied in mice systems in vivo. The obtained results testify to the possibility of existence of inductor mechanisms for activation of the effector cells of immunobiologic surveillance. It is supposed that gamma-INF is a binding chain of the natural host resistance.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma.
April 1984, Cellular immunology,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.
July 1988, Proceedings of the National Academy of Sciences of the United States of America,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Cytokine mediated regulation of interferon-gamma-induced IDO activation.
January 1999, Advances in experimental medicine and biology,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.
May 1998, The EMBO journal,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.
January 1981, Journal of immunology (Baltimore, Md. : 1950),
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Interferon-gamma protects human endothelial cells from lymphokine-activated killer cell-mediated lysis.
November 1988, European journal of immunology,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Regulation of lymphokine (gamma-interferon) production by corticotropin.
January 1984, Journal of immunology (Baltimore, Md. : 1950),
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells.
September 1992, Neurosurgery,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill.
June 2007, Immunology,
F V Fil'chakov, and I V Fil'chakov, and Iu A Grinevich, and S V Martynenko, and V K Ivanenko
Interferon-gamma-induced alterations of monocyte susceptibility to lysis by autologous lymphokine-activated killer (LAK) cells.
September 1988, International journal of cancer,
Copied contents to your clipboard!